About this trial
Presence of keratinized tissue (KT) around dental implants, plays a crucial role in stability and health of peri-implant tissues. Several studies reported that, minimum of 2 mm keratinized tissue width is required to achieve long-term longevity. Insufficient keratinized mucosa leads to biofilm accumulation, soft tissue inflammation, eventually peri-implant mucositis and peri-implantitis. Hence, the aim of the present trial is to evaluate KTW gain, linear and volumetric changes in buccal soft tissue along with hard tissue alterations following implant restoration at sites treated either with delayed implant placement \& simultaneous FGG or the conventional FGG protocol prior to implant placement.
Eligibility criteria
Qualifiers
Adults at or above the age of 18.
Lower Posterior missing tooth/ teeth with minimal KT < 2mm
Sufficient alveolar ridge length minimum 13-15 mm to IAN
Patients able to tolerate surgical periodontal procedures.
Disqualifiers
Patients diagnosed with periodontal diseases (Caton et al., 2018).
Current or previous smokers.
Pregnant and lactating females.
Patients with medical conditions that would compromise the surgical procedures; uncontrolled diabetes mellitus, taking intravenous Bisphosphonates for treatment of osteoporosis.
Trial design
Treatments tested in this trial
- One Step Protocol
- Two Steps Protocol
Treatment groups
Sponsors and collaborators
Misr International University
Lead sponsor
International Dental Contiuing Education
Sponsor institution
International Dental Contiuing Education
Collaborator